Genesis Healthcare (GENN) Short Interest Ratio & Short Volume

Short interest is the volume of Genesis Healthcare shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 19,400 shares of GENN short. 0.01% of Genesis Healthcare's shares are currently sold short. Learn More on Genesis Healthcare's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GENN shares currently have a short interest ratio of 4.0. Learn More on Genesis Healthcare's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Genesis Healthcare's floating shares are currently sold short.

0.01% of Genesis Healthcare's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Genesis Healthcare: IMAC Holdings, Inc. (2.16%), Skylight Health Group Inc. (0.01%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

Short selling GENN is an investing strategy that aims to generate trading profit from Genesis Healthcare as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Genesis Healthcare occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GENN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GENN, twice per month. The most recent reporting period available is April, 15 2025.